Pharmesis International (SGX:BFK) FCF Margin % : 5.17% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmesis International's Free Cash Flow for the six months ended in Dec. 2023 was S$0.17 Mil. Pharmesis International's Revenue for the six months ended in Dec. 2023 was S$3.35 Mil. Therefore, Pharmesis International's FCF Margin % for the quarter that ended in Dec. 2023 was 5.17%.

As of today, Pharmesis International's current FCF Yield % is -104.21%.

The historical rank and industry rank for Pharmesis International's FCF Margin % or its related term are showing as below:

SGX:BFK' s FCF Margin % Range Over the Past 10 Years
Min: -46.9 Med: -1.21 Max: 14.65
Current: -26.9

During the past 13 years, the highest FCF Margin % of Pharmesis International was 14.65%. The lowest was -46.90%. And the median was -1.21%.

SGX:BFK's FCF Margin % is ranked worse than
79.88% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.085 vs SGX:BFK: -26.90

Pharmesis International FCF Margin % Historical Data

The historical data trend for Pharmesis International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmesis International FCF Margin % Chart

Pharmesis International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-10.91

1.65

-1.76

12.56

-26.80

Pharmesis International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															3.32	-10.36	26.17	-47.52	5.17

Competitive Comparison of Pharmesis International's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmesis International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmesis International's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmesis International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmesis International's FCF Margin % falls into.

Pharmesis International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmesis International's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.282	/	8.514
	=	-26.80 %

Pharmesis International's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0.173	/	3.347
	=	5.17 %

Pharmesis International FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pharmesis International's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmesis International (SGX:BFK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Kallang Sector, No. 03-02, Singapore, SGP, 349279

Website

https://www.pharmesis.com

Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its geographical segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.

Pharmesis International (SGX:BFK) Headlines

From GuruFocus

Certain BlackRock Municipal Closed-End Funds Announce Variable Rate Muni Term Preferred Shares Actions

By Business Wire • 11-02-2023